Delivery Order SPE2DB20D1110-SPE2DB25FK36S
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a $3,537.98 delivery order to AmerisourceBergen Drug Corp for 1,000 units of Synthroid 25 micrograms on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement under delivery order contract type. The award was placed to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the vendor is headquartered...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,630.09 to AmerisourceBergen Drug Corp for the supply of Synthroid 50 MCG tablets (1,000 units) on September 8, 2025, with an ultimate completion date of September 9, 2025. This non-set-aside contract employs firm fixed pricing and is classified as a delivery order under the competitive procurement process. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Synthroid 100 micrograms tablets in quantities of 1,000 units, with a ceiling value of $1,061.94. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is due for completion by September 16, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Synthroid 100 microgram tablets in quantities of 1,000 units, with a ceiling value of $1,678.76. This non-competitive, firm fixed price delivery order is set to be completed by September 10, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of 1,000 tablets of Synthroid 25 micrograms, with a ceiling value of $1,539.70. This competitively awarded, firm fixed-price delivery order is not subject to any set-aside designation and is scheduled for completion by August 6, 2025. The pharmaceutical products will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Synthroid 25 MCG tablets (1,000 count) on July 22, 2025, with a ceiling value of $1,090.43. The contract employs firm fixed price pricing and is scheduled for ultimate completion by July 23, 2025. This delivery order is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a prime...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Synthroid 75 mcg on June 17, 2025, with a ceiling value of $1,886.88. This competitively awarded, firm fixed-price delivery order is scheduled for completion by June 18, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract includes no set-aside designation, reflecting AmerisourceBergen's competitive standing in federal pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $6,931.37 to AmerisourceBergen Drug Corp for 1,000 tablets of Synthroid 50 micrograms. The contract, issued on September 11, 2025, with an ultimate completion date of September 12, 2025, utilizes firm fixed pricing with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Synthroid 100 microgram tablets in quantities of 1,000 units. This firm fixed-price delivery order, valued at $1,478.35, represents a child contract under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion prime vendor agreement running through December 2026. The contract involves no set-aside designation and...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $50,535.07 delivery order on July 18, 2025, for the supply of 1,000 tablets of Synthroid 137 micrograms. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with the agency. Performance will be completed by July 21, 2025, with fulfillment occurring at the company's corporate office location in Conshohocken, Pennsylvania....
- SPE2DB20D1110Indefinite Delivery Contract
- SPE2DB20D1110-SPE2DB25FK36SDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,041.98 to AmerisourceBergen Drug Corp for the supply of Synthroid 25 microgram tablets (90-count units) on August 26, 2025, with completion expected by August 27, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. The IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract encompasses specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 8/26/25 |